Cytokinetics
CYTK
C$50.32
Share price
-1.48%
Change (1 day)
-38.54%
Change (1 year)
Categories
Cytokinetics (CYTK) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$2.10 Billion
According to Cytokinetics 's latest financial reports the company's total liabilities are C$2.10 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cytokinetics - Total liabilities on balance sheet (from 2003 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$2.20 B | 37.36% |
| 2023-12-31 | C$1.60 B | 5.4% |
| 2022-12-31 | C$1.52 B | 100.07% |
| 2021-12-31 | C$0.76 B | 42.04% |
| 2020-12-31 | C$0.53 B | 36.47% |
| 2019-12-31 | C$0.39 B | 55.66% |
| 2018-12-31 | C$0.25 B | 8.51% |
| 2017-12-31 | C$0.23 B | 128.35% |
| 2016-12-31 | C$0.10 B | 57.38% |
| 2015-12-31 | C$64.7 M | 36.32% |
| 2014-12-31 | C$47.46 M | 55.12% |
| 2013-12-31 | C$30.6 M | 312.17% |
| 2012-12-31 | C$7.42 M | 58.84% |
| 2011-12-31 | C$4.67 M | -37.45% |
| 2010-12-31 | C$7.47 M | -66.45% |
| 2009-12-31 | C$22.27 M | -51.39% |
| 2008-12-31 | C$45.82 M | -17.17% |
| 2007-12-31 | C$55.32 M | -24.82% |
| 2006-12-31 | C$73.58 M | 253.1% |
| 2005-12-31 | C$20.84 M | -15.55% |
| 2004-12-31 | C$24.67 M | -87.72% |
| 2003-12-31 | C$0.20 B | 8.97% |
| 2002-12-31 | C$0.18 B | -0.53% |
| 2001-12-31 | C$0.18 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | C$0.15 B | -92.82% | 🇺🇸 USA |
 Trevena TRVN | C$58.37 M | -97.22% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | C$0.36 B | -82.53% | 🇺🇸 USA |
 Amgen AMGN | C$114.23 B | 5,333.66% | 🇺🇸 USA |
 Array Technologies ARRY | C$1.51 B | -27.99% | 🇺🇸 USA |